	US 12,484,583 B2
	Antifungal composition comprising natamycin and at least one insecticide
Wilhelmus Maria Van Der Krieken, Wageningen (NL)
Assigned to Ceradis Patent B.V., Wageningen (NL)
Appl. No. 17/630,313
Filed by Ceradis Patent B.V., Wageningen (NL)
PCT Filed Aug. 13, 2020, PCT No. PCT/NL2020/050511 § 371(c)(1), (2) Date Jan. 26, 2022, PCT Pub. No. WO2021/029770, PCT Pub. Date Feb. 18, 2021.
Claims priority of application No. 19191549 (EP), filed on Aug. 13, 2019.
Prior Publication US 2022/0256856 A1, Aug. 18, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A01N 43/90 (2006.01); A01N 25/10 (2006.01); A01N 43/40 (2006.01); A01N 43/50 (2006.01); A01N 43/56 (2006.01); A01N 43/78 (2006.01); A01N 43/88 (2006.01); A01N 53/00 (2006.01); A01P 3/00 (2006.01)

CPC A01N 43/90 (2013.01) [A01N 25/10 (2013.01); A01N 43/40 (2013.01); A01N 43/50 (2013.01); A01N 43/56 (2013.01); A01N 43/78 (2013.01); A01N 43/88 (2013.01); A01N 53/00 (2013.01); A01P 3/00 (2021.08)]

15 Claims

1. An antifungal composition comprising natamycin and at least one insecticide that interferes with the nervous system and/or muscular system of insects and nematodes, wherein the volume-based average particle size of natamycin is between 0.2 and 10 micrometers, wherein said at least one insecticide is selected from the group consisting of emamectin benzoate, fipronil, lambda-cyhalothrin, imidacloprid, thiamethoxam, abamectin and chlorantraniliprole, and wherein the ratio of natamycin to the at least one insecticide is between 1:1 and 1:2500 (w/w).